Does CBD get you high?

No. CBD does not produce intoxication. It does not bind directly to the CB1 receptors responsible for the cannabis high. Some users report feeling calmer or less anxious, but this is qualitatively different from being high on THC.

The strongest evidence is for severe pediatric epilepsy (Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex), where CBD is FDA-approved as Epidiolex at doses of 5-20 mg/kg/day. Promising but not FDA-approved evidence exists for anxiety, sleep, inflammation, and PTSD. Many marketed claims (cancer, dementia, diabetes) lack high-quality clinical support.

How much CBD should I take?

It depends on the use case. Severe seizures: 5-20 mg/kg/day under medical supervision (350-1,400 mg/day for a 70 kg adult). Acute anxiety: ~300 mg single dose per the Linares 2019 dose-ranging study. General wellness: 15-50 mg/day, though this is below clinical-trial doses and effects may be subtle. Most off-the-shelf gummies dose at 5-25 mg per serving — often too low to replicate the effects shown in successful trials.

Will CBD make me fail a drug test?

Pure CBD itself will not. However, full-spectrum CBD products contain up to 0.3% THC by dry weight, and daily use of moderate to high doses can accumulate enough THC to trigger a positive test. Mislabeled products may contain more THC than declared. If you are subject to drug testing, use CBD isolate from reputable brands with third-party Certificates of Analysis (COAs).

Is CBD safe to take with other medications?

Not always. CBD inhibits several CYP450 liver enzymes (notably CYP2C19 and CYP3A4) that metabolize many prescription drugs. CBD can change blood levels of warfarin, certain antidepressants, antiepileptics, and others — clinically significant. The Epidiolex label carries a Hepatocellular Injury warning. Talk to your pharmacist before combining CBD with any prescription medication.

What Is CBD? The Non-Intoxicating Cannabis Compound

Medical Disclaimer: This information is educational only and does not constitute medical advice. Cannabis affects everyone differently. Always consult a qualified healthcare provider before using cannabis, especially if you take other medications. Never discontinue prescribed medications without medical supervision.

The Short Answer

CBD stands for cannabidiol. It is a non-intoxicating cannabinoid found in the cannabis plant — including in hemp varieties, which are legally defined as cannabis containing less than 0.3% THC. Unlike THC, CBD does not produce a high, does not impair driving in the way THC does, and does not show up on most standard drug tests (with caveats — see below).

CBD has documented therapeutic effects for a small number of well-studied conditions and a much larger market of products with thinner evidence behind them. Sorting the science from the marketing is the most useful thing you can do as a consumer.

How CBD Works in the Body

Where THC works by binding directly to CB1 receptors in the brain, CBD takes a fundamentally different approach. CBD has only weak direct affinity for CB1 (about 50–300 times less than THC) and produces effects through at least seven distinct mechanisms:

Negative allosteric modulator at CB1 — CBD binds to a different site on the CB1 receptor and dampens the receptor’s response to agonists, including THC. This is why CBD can “take the edge off” a too-strong THC experience.
Partial agonist at 5-HT1A serotonin receptors — the same receptor targeted by buspirone and similar anxiolytics. Likely the basis of CBD’s anxiety-reducing effects.
GPR55 antagonist — an “orphan” receptor implicated in pain signaling and inflammation.
TRPV1 agonist — the same receptor activated by capsaicin (chili peppers); contributes to anti-inflammatory effects.
Adenosine reuptake inhibition — raises adenosine levels, contributing to anti-inflammatory and possibly sedative effects.
PPARγ agonist — nuclear receptor involved in metabolism and inflammation.
FAAH inhibition — slows the breakdown of anandamide (the body’s own endocannabinoid), indirectly increasing endocannabinoid tone.

This complex pharmacology is one reason CBD’s effects are subtle, hard to predict, and dose-dependent in a non-linear way.

What CBD Is FDA-Approved For

The FDA has approved exactly one CBD-derived drug:

Epidiolex — a purified CBD oral solution approved in 2018 for seizures associated with Dravet syndrome, Lennox-Gastaut syndrome, and (since 2020) tuberous sclerosis complex. Pivotal trials showed a 39–50% reduction in convulsive seizures vs. placebo.

Epidiolex is the strongest evidence in cannabinoid medicine. Doses are high — 5–20 mg/kg/day — meaning a 70 kg adult takes roughly 350–1,400 mg of CBD per day. This is the dose range required to control seizures, and it is dramatically higher than what a typical consumer CBD product delivers.

What CBD Is Promising (But Not Yet FDA-Approved) For

Anxiety — the Bergamaschi 2011 social anxiety trial used 600 mg of CBD; the Linares 2019 dose-ranging study found 300 mg was the “sweet spot” with both 150 mg and 600 mg producing weaker effects (an inverted U-shaped dose response).
Insomnia and sleep — mixed evidence; some studies show benefit at 25–160 mg, others find no effect.
Inflammation and certain pain conditions — preclinical evidence is strong but human RCT evidence is thin. A 2025 OHSU meta-analysis found CBD-only products showed minimal pain improvement vs. placebo.
PTSD — small trials show promise; large trials in progress.
Substance use disorder (alcohol, opioids, cannabis) — emerging evidence, not yet clinically established.

What CBD Is Not Proven For (Despite the Marketing)

The consumer CBD market is awash in claims unsupported by rigorous evidence. As of May 2026, there is no high-quality clinical evidence that CBD treats:

Cancer
Alzheimer’s disease or dementia (preclinical research is interesting; human evidence is absent)
Diabetes
Skin conditions (acne, psoriasis, eczema) — topical CBD has anti-inflammatory plausibility but RCT evidence is limited
Heart disease
Erectile dysfunction

Marketing claims that CBD “treats” or “cures” any of these conditions are not supported by the published evidence base.

How Much CBD Should You Take?

The honest answer: it depends on what you’re trying to accomplish, and many consumer doses are too low to do anything. General reference points:

Use case	Typical effective range	Notes
Severe seizures (Epidiolex indication)	5–20 mg/kg/day	~350–1,400 mg/day for a 70 kg adult; requires medical supervision
Acute anxiety	~300 mg single dose	Per Linares 2019 dose-ranging study
General wellness / mild anxiety	15–50 mg/day	Below clinical-trial doses; effects may be subtle or placebo-driven
Sleep	25–160 mg before bed	Mixed evidence; often combined with melatonin or CBN
Topical (skin/joint)	Local application	Systemic absorption is minimal; effects are localized

Most off-the-shelf gummies and tinctures dose at 5–25 mg per serving — well below the doses used in successful clinical trials. If you’re not feeling anything from CBD, the most likely explanation is that the dose is too low for the effect you want, not that “CBD doesn’t work.”

Is CBD Safe?

CBD has a generally favorable safety profile but is not entirely benign. Documented concerns:

Drug interactions. CBD inhibits several CYP450 liver enzymes (notably CYP2C19 and CYP3A4) that metabolize many prescription drugs. The Epidiolex label carries a Hepatocellular Injury warning: in trials, 21% of patients on CBD plus valproate developed elevated liver enzymes. CBD can change blood levels of warfarin, certain antidepressants, antiepileptics, and many others — clinically significant. Talk to your pharmacist before combining CBD with any medication.
Side effects. Most commonly: drowsiness, diarrhea, decreased appetite, dry mouth. Generally mild and dose-related.
Product quality. A 2017 JAMA study analyzed 84 online CBD products; only 31% were accurately labeled. 43% contained more CBD than claimed, 26% contained less, and 21% contained THC despite being labeled CBD-only. Buy from brands that publish third-party Certificates of Analysis (COAs) — if no COA is available, do not buy.

Will CBD Show Up on a Drug Test?

Standard drug tests look for THC metabolites, not CBD. Pure CBD will not produce a positive result. However:

Full-spectrum CBD products contain up to 0.3% THC by dry weight. Daily use of moderate to high doses can accumulate enough THC to trigger a positive test.
Mislabeled products may contain more THC than declared.
CBD isolate products from reputable brands with verified COAs are the safest choice for anyone subject to drug testing.

CBD vs. Hemp Oil vs. Cannabis Oil

These terms get used interchangeably in marketing but mean different things:

CBD oil — an extract from cannabis or hemp that is concentrated in CBD. The CBD content should be stated on the label in milligrams (e.g., “1,000 mg CBD per 30 mL bottle”).
Hemp oil — can mean either CBD oil OR hemp seed oil (which contains essentially no CBD). Read the label carefully. Hemp seed oil is a culinary oil; CBD oil is a cannabinoid product.
Cannabis oil — broad term that can mean THC-dominant, CBD-dominant, or balanced extracts. Context-dependent; check the cannabinoid profile.
Full-spectrum vs. broad-spectrum vs. isolate — full-spectrum contains all cannabinoids and terpenes from the source plant including up to 0.3% THC; broad-spectrum has THC removed; isolate is pure CBD with everything else removed.

Legal Status

Hemp-derived CBD (containing under 0.3% THC by dry weight) has been federally legal in the U.S. since the 2018 Farm Bill. This is why CBD products appear in gas stations, grocery stores, and pharmacies nationwide. Some states have additional restrictions on CBD as a food/beverage additive.

Cannabis-derived CBD (extracted from cannabis containing more than 0.3% THC) remains federally Schedule I but is legal under the medical or adult-use programs of most U.S. states.

Outside the U.S., CBD legal status varies enormously. Some countries treat hemp-derived CBD like a normal supplement (UK, EU under specific Novel Foods rules). Others classify it as a medicine requiring prescription. A few prohibit it entirely. See CannabisTravel.org before traveling internationally with CBD.

The Bottom Line

CBD is a real medicine for severe pediatric epilepsy and a credible candidate for anxiety. Beyond those two uses, the evidence is thinner than the marketing suggests — not zero, but not what the consumer market implies. Doses in most off-the-shelf products are too low for the effects shown in successful clinical trials. Drug interactions are real and clinically significant. Product quality is wildly inconsistent.

If you’re considering CBD: start with a known-good brand that publishes COAs, set realistic expectations about effect size, talk to your pharmacist if you take any prescription medications, and don’t expect a 10 mg gummy to do what 300 mg in a clinical trial did.